Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients

NCT01846260 is registered in ClinicalTrials.gov with General Hospital Groeninge as lead sponsor.

NCT NCT01846260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01846260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients
Lead sponsor
General Hospital Groeninge
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
March 31, 2016
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients eligible for a treatment with curative intent, cognitive impairment